VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1561091
Sex: F
Age:
State: WI

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Patient started experiencing pain in muscle and bones in left arm; Patient started experiencing pain in muscle and bones in left arm; Neck pain (with radiation); Patient reported sore arm after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Patient reported sore arm after receiving 1st dose), BONE PAIN (Patient started experiencing pain in muscle and bones in left arm), NECK PAIN (Neck pain (with radiation)) and MYALGIA (Patient started experiencing pain in muscle and bones in left arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination. No medical history was reported. Concomitant products included ATENOLOL, HYDROCHLOROTHIAZIDE and LOVASTATIN for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Patient reported sore arm after receiving 1st dose). On 22-Feb-2021, the patient experienced NECK PAIN (Neck pain (with radiation)). On 02-Mar-2021, the patient experienced BONE PAIN (Patient started experiencing pain in muscle and bones in left arm) and MYALGIA (Patient started experiencing pain in muscle and bones in left arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Patient reported sore arm after receiving 1st dose), BONE PAIN (Patient started experiencing pain in muscle and bones in left arm), NECK PAIN (Neck pain (with radiation)) and MYALGIA (Patient started experiencing pain in muscle and bones in left arm) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, X-ray: normal (normal) MD did x-ray and couldn't find anything. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ATENOLOL; HYDROCHLOROTHIAZIDE; LOVASTATIN

Current Illness:

ID: 1561092
Sex: F
Age: 81
State: OH

Vax Date: 01/21/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: washed out feeling; Felt worse; Headache; Felt terrible; Achy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt terrible), PAIN (Achy), MALAISE (Felt worse), HEADACHE (Headache) and FATIGUE (washed out feeling) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 0131L20A) for COVID-19 vaccination. Concurrent medical conditions included Arthritis and Hypothyroidism. Concomitant products included LEVOTHYROXINE for Hypothyroidism. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced FEELING ABNORMAL (Felt terrible), PAIN (Achy) and HEADACHE (Headache). On 27-Feb-2021, the patient experienced MALAISE (Felt worse). On 02-Mar-2021, the patient experienced FATIGUE (washed out feeling). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Felt terrible), PAIN (Achy), MALAISE (Felt worse), HEADACHE (Headache) and FATIGUE (washed out feeling) outcome was unknown. Patient reported that she took two Tylenol. On 27 Feb 2021, she stated that she "felt worse" and took two additional Tylenol. Action taken with mRNA-1273 in response to events was not applicable.

Other Meds: LEVOTHYROXINE

Current Illness: Arthritis; Hypothyroidism

ID: 1561093
Sex: M
Age: 49
State: OK

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Lower left side abdominal pain; Acute abdominal pain; stiff arm; fatigue; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Acute abdominal pain), ABDOMINAL PAIN (Lower left side abdominal pain), MUSCLE SPASTICITY (stiff arm), FATIGUE (fatigue) and MYALGIA (muscle pain) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced MUSCLE SPASTICITY (stiff arm), FATIGUE (fatigue) and MYALGIA (muscle pain). On 27-Feb-2021, the patient experienced ABDOMINAL PAIN (Acute abdominal pain). On 02-Mar-2021, the patient experienced ABDOMINAL PAIN (Lower left side abdominal pain). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN (Acute abdominal pain) outcome was unknown, ABDOMINAL PAIN (Lower left side abdominal pain) had not resolved and MUSCLE SPASTICITY (stiff arm), FATIGUE (fatigue) and MYALGIA (muscle pain) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications reported were none.

Other Meds:

Current Illness:

ID: 1561094
Sex: F
Age: 61
State: CA

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: nausea; This spontaneous case was reported by a physician and describes the occurrence of NAUSEA (nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No medical history was reported. Concomitant products included VITAMINS NOS for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced NAUSEA (nausea). At the time of the report, NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment information was provided.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1561095
Sex: F
Age:
State: MI

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Patient vomited for 3 times; really bad watery diarrhea; diarrhea got worse 4 days later; Patient started getting diarrhea 2 days after receving 2nd dose of vaccine; Patient started getting chills; nausea on same night of receiving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Patient started getting diarrhea 2 days after receving 2nd dose of vaccine), DIARRHOEA (really bad watery diarrhea), DIARRHOEA (diarrhea got worse 4 days later), CHILLS (Patient started getting chills) and VOMITING (Patient vomited for 3 times) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported. Concomitant products included QUETIAPINE FUMARATE (SEROQUEL), ASENAPINE MALEATE (SAPHRIS), CLONAZEPAM (KLONOPIN) and TRAZODONE for an unknown indication. On 19-Feb-2021 at 10:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced CHILLS (Patient started getting chills) and NAUSEA (nausea on same night of receiving 2nd dose). On 21-Feb-2021, the patient experienced DIARRHOEA (Patient started getting diarrhea 2 days after receving 2nd dose of vaccine). On 25-Feb-2021, the patient experienced DIARRHOEA (diarrhea got worse 4 days later). On 26-Feb-2021, the patient experienced DIARRHOEA (really bad watery diarrhea). On 28-Feb-2021, the patient experienced VOMITING (Patient vomited for 3 times). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) for Diarrhoea, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Patient started getting diarrhea 2 days after receving 2nd dose of vaccine), DIARRHOEA (really bad watery diarrhea), DIARRHOEA (diarrhea got worse 4 days later), CHILLS (Patient started getting chills), VOMITING (Patient vomited for 3 times) and NAUSEA (nausea on same night of receiving 2nd dose) outcome was unknown. Action taken with mRNA-1273 in response to events was not applicable.

Other Meds: SEROQUEL; SAPHRIS; KLONOPIN; TRAZODONE

Current Illness:

ID: 1561096
Sex: M
Age: 49
State: OK

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Lower left side abdominal pain; Acute abdominal pain; stiff arm; Muscle pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Acute abdominal pain), ABDOMINAL PAIN (Lower left side abdominal pain), MUSCULOSKELETAL STIFFNESS (stiff arm), MYALGIA (Muscle pain) and FATIGUE (fatigue) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff arm), MYALGIA (Muscle pain) and FATIGUE (fatigue). On 27-Feb-2021, the patient experienced ABDOMINAL PAIN (Acute abdominal pain). On 02-Mar-2021, the patient experienced ABDOMINAL PAIN (Lower left side abdominal pain). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN (Acute abdominal pain) and ABDOMINAL PAIN (Lower left side abdominal pain) outcome was unknown and MUSCULOSKELETAL STIFFNESS (stiff arm), MYALGIA (Muscle pain) and FATIGUE (fatigue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications reported were none.

Other Meds:

Current Illness:

ID: 1561097
Sex: F
Age: 26
State: CT

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Rash at the injection site and arm; Rash in arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the injection site and arm) and RASH (Rash in arm) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site and arm) and RASH (Rash in arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (Rash at the injection site and arm) and RASH (Rash in arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. List of concomitant medication were not given.

Other Meds:

Current Illness:

ID: 1561098
Sex: M
Age: 63
State: TX

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Achy; Exhausted; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achy), FATIGUE (Exhausted) and CHILLS (Chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. Concomitant products included ATORVASTATIN, LISINOPRIL and NABUMETONE for an unknown indication. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MYALGIA (Achy), FATIGUE (Exhausted) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, MYALGIA (Achy), FATIGUE (Exhausted) and CHILLS (Chills) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) he had Covid 6 months ago. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: TCR Received. Significant FU- AE Outcomes updated

Other Meds: ATORVASTATIN; LISINOPRIL; NABUMETONE

Current Illness:

ID: 1561099
Sex: F
Age: 82
State: NC

Vax Date: 02/26/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: reaction after three days; wasn't feeling well; too weak to get ready to go; getting fatigue; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (reaction after three days), MALAISE (wasn't feeling well), ASTHENIA (too weak to get ready to go), FATIGUE (getting fatigue) and MYALGIA (muscle pain) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot# 014M20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced ADVERSE REACTION (reaction after three days), MALAISE (wasn't feeling well), ASTHENIA (too weak to get ready to go), FATIGUE (getting fatigue) and MYALGIA (muscle pain). At the time of the report, ADVERSE REACTION (reaction after three days), MALAISE (wasn't feeling well), ASTHENIA (too weak to get ready to go), FATIGUE (getting fatigue) and MYALGIA (muscle pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient stated that I just got my first dose of Moderna vaccine last Friday on 26feb2021 and I was fine until now. Today I started getting fatigue and muscle pain. I had doctor's appointment but I wasn't feeling well so I couldn't go. I was too weak to get ready to go. Is it okay to get the reaction after three days?

Other Meds:

Current Illness:

ID: 1561100
Sex: F
Age: 80
State: AL

Vax Date: 02/02/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Breast swollen like a water balloon; Whole side from shoulder to feet is swollen; Armpit hurting; Swollen area tender; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (Breast swollen like a water balloon), SWELLING (Whole side from shoulder to feet is swollen), AXILLARY PAIN (Armpit hurting) and TENDERNESS (Swollen area tender) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced BREAST SWELLING (Breast swollen like a water balloon), SWELLING (Whole side from shoulder to feet is swollen), AXILLARY PAIN (Armpit hurting) and TENDERNESS (Swollen area tender). At the time of the report, BREAST SWELLING (Breast swollen like a water balloon), SWELLING (Whole side from shoulder to feet is swollen), AXILLARY PAIN (Armpit hurting) and TENDERNESS (Swollen area tender) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication and treatment medication was provided.

Other Meds:

Current Illness:

ID: 1561101
Sex: U
Age: 77
State: IL

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Exceeded dosing interval; Fatigue; A spontaneous report (United States) was received from a consumer for a 78 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue. It was known the patient had exceeded dosing interval. The patient's medical history included chronic obstructive pulmonary disease. Concomitant medication included inhaler. On 29-Jan-2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 012L20A) intramuscularly for prophylaxis of COVID-19 infection. It was known the patient had exceeded the dosing interval. On 29-Jan-2021, an unspecified interval after receiving the vaccine the patient experienced fatigue. Treatment information was unknown. Action taken with mRNA-1273 was unknown. The outcome of the events, exceeded dosing interval was not applicable and for the event fatigue was unknown.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273, lot 012L20A with no associated AEs. Based on the current available information and temporal association between the use of the product and the start date of the fatigue, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1561102
Sex: F
Age: 54
State: MS

Vax Date: 01/19/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Redness; itchy; tender; This spontaneous case was reported by a health care professional and describes the occurrence of in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications and treatment information were reported. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow up received on 04-MAY-2021 Contains Age of the patient was added

Other Meds:

Current Illness:

ID: 1561103
Sex: F
Age: 73
State: CA

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Pain at the injection site; Itchiness at the injection site; Rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE RASH (Rash at the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE RASH (Rash at the injection site). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE PRURITUS (Itchiness at the injection site) and VACCINATION SITE RASH (Rash at the injection site) outcome was unknown. No treatment information provided, no concomitant medications reported. Patient called to report her adverse events Pain, Itchiness and Rash at the injection site, following her second shot of MODERNA COVID 19 Vaccine intramuscularly on the left arm, last Friday, 26FEB2021. Consumer confirmed using ice pack. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021:

Other Meds:

Current Illness:

ID: 1561104
Sex: U
Age: 46
State: AZ

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: thumb not straight; fatigue; nausea; cold extremities; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever), MUSCLE SPASMS (thumb not straight), FATIGUE (fatigue) and NAUSEA (nausea) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00417120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. NO Medical History Information was reported. On 29-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced CHILLS (chills) and PYREXIA (fever). On 30-Jan-2021, the patient experienced MUSCLE SPASMS (thumb not straight), FATIGUE (fatigue), NAUSEA (nausea) and PERIPHERAL COLDNESS (cold extremities). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK, bid. On 30-Jan-2021, CHILLS (chills), PYREXIA (fever), MUSCLE SPASMS (thumb not straight) and NAUSEA (nausea) had resolved. On 31-Jan-2021, FATIGUE (fatigue) and PERIPHERAL COLDNESS (cold extremities) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Feb-2021 and was forwarded to Moderna on 11-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever), MUSCLE SPASMS (thumb not straight), FATIGUE (fatigue) and NAUSEA (nausea) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00417120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. NO Medical History Information was reported. On 29-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced CHILLS (chills) and PYREXIA (fever). On 30-Jan-2021, the patient experienced MUSCLE SPASMS (thumb not straight), FATIGUE (fatigue), NAUSEA (nausea) and PERIPHERAL COLDNESS (cold extremities). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK, bid. On 30-Jan-2021, CHILLS (chills), PYREXIA (fever), MUSCLE SPASMS (thumb not straight) and NAUSEA (nausea) had resolved. On 31-Jan-2021, FATIGUE (fatigue) and PERIPHERAL COLDNESS (cold extremities) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1561105
Sex: M
Age: 91
State: NJ

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: vomited about 3 times; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomited about 3 times) and DIARRHOEA (diarrhea) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History Information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VOMITING (vomited about 3 times) and DIARRHOEA (diarrhea). At the time of the report, VOMITING (vomited about 3 times) and DIARRHOEA (diarrhea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Feb-2021 and was forwarded to Moderna on 12-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomited about 3 times) and DIARRHOEA (diarrhea) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History Information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VOMITING (vomited about 3 times) and DIARRHOEA (diarrhea). At the time of the report, VOMITING (vomited about 3 times) and DIARRHOEA (diarrhea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1561106
Sex: F
Age: 80
State: NY

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: swollen lip and cracking on one side and sores; really severe pain in her hip for three days; really tired; headache; achy; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swollen lip and cracking on one side and sores), ARTHRALGIA (really severe pain in her hip for three days), FATIGUE (really tired), HEADACHE (headache) and PAIN (achy) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical history information was reported. On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced LIP SWELLING (swollen lip and cracking on one side and sores), ARTHRALGIA (really severe pain in her hip for three days), FATIGUE (really tired), HEADACHE (headache), PAIN (achy) and INJECTION SITE PAIN (pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, LIP SWELLING (swollen lip and cracking on one side and sores), ARTHRALGIA (really severe pain in her hip for three days), FATIGUE (really tired), HEADACHE (headache), PAIN (achy) and INJECTION SITE PAIN (pain at the injection site) outcome was unknown. No relevant concomitant medications were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Feb-2021 and was forwarded to Moderna on 11-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swollen lip and cracking on one side and sores), ARTHRALGIA (really severe pain in her hip for three days), FATIGUE (really tired), HEADACHE (headache) and PAIN (achy) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical history information was reported. On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced LIP SWELLING (swollen lip and cracking on one side and sores), ARTHRALGIA (really severe pain in her hip for three days), FATIGUE (really tired), HEADACHE (headache), PAIN (achy) and INJECTION SITE PAIN (pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, LIP SWELLING (swollen lip and cracking on one side and sores), ARTHRALGIA (really severe pain in her hip for three days), FATIGUE (really tired), HEADACHE (headache), PAIN (achy) and INJECTION SITE PAIN (pain at the injection site) outcome was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1561107
Sex: F
Age: 79
State: FL

Vax Date: 02/04/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: sore left arm; red area of some couple of inches around the injection site; a little swollen; hard to touch but not painful; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), VACCINATION SITE ERYTHEMA (red area of some couple of inches around the injection site), SWELLING (a little swollen) and MUSCLE RIGIDITY (hard to touch but not painful) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included Hypertension since an unknown date. Concomitant products included THYROID for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red area of some couple of inches around the injection site), SWELLING (a little swollen) and MUSCLE RIGIDITY (hard to touch but not painful). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore left arm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore left arm), VACCINATION SITE ERYTHEMA (red area of some couple of inches around the injection site), SWELLING (a little swollen) and MUSCLE RIGIDITY (hard to touch but not painful) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications reported were blood pressure medication, Thyroid medication, and blood thinner for drug use for unknown indication. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Feb-2021 and was forwarded to Moderna on 12-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), VACCINATION SITE ERYTHEMA (red area of some couple of inches around the injection site), SWELLING (a little swollen) and MUSCLE RIGIDITY (hard to touch but not painful) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included Hypertension since an unknown date. Concomitant products included THYROID for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red area of some couple of inches around the injection site), SWELLING (a little swollen) and MUSCLE RIGIDITY (hard to touch but not painful). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore left arm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore left arm), VACCINATION SITE ERYTHEMA (red area of some couple of inches around the injection site), SWELLING (a little swollen) and MUSCLE RIGIDITY (hard to touch but not painful) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications reported were blood pressure medication, Thyroid medication, and blood thinner for drug use for unknown indication.

Other Meds: THYROID

Current Illness: Hypertension

ID: 1561108
Sex: M
Age:
State: FL

Vax Date: 03/02/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Blood pressure is high(150/100); Fever (99.7F); This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Blood pressure is high(150/100)) and PYREXIA (Fever (99.7F)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced HYPERTENSION (Blood pressure is high(150/100)) and PYREXIA (Fever (99.7F)). At the time of the report, HYPERTENSION (Blood pressure is high(150/100)) and PYREXIA (Fever (99.7F)) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Blood pressure measurement: 150/100 mmhg (High) High. On 03-Mar-2021, Body temperature: 99.7 (High) Fever (99.7F). Concomitant medications were not provided by the reporter. No treatment information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Event outcome updated

Other Meds:

Current Illness:

ID: 1561109
Sex: F
Age: 69
State: AL

Vax Date: 03/03/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever) and PAIN (hurting all over) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included CELECOXIB (CELEBREX) and PREDNISONE for an unknown indication. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever) and PAIN (hurting all over). At the time of the report, CHILLS (chills), PYREXIA (fever) and PAIN (hurting all over) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications include Nebulizer, Libutrin and Valirest. Treatment medications include Motrin and Aleve. Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: NNI

Other Meds: CELEBREX; PREDNISONE

Current Illness:

ID: 1561110
Sex: F
Age: 56
State: IL

Vax Date: 05/20/2021
Onset Date: 05/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies: penicillins, Keflex, benadryl

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Developed swelling/pain in lymph nodes of left armpit about 8 hours after vaccination. At 10 hours after vaccination, developed chills and fever of 102.7. Took Tylenol 650 mg every 6 hours for 48 hours. chills and fever >102.7 lasted for 26 hours. I could only manage getting up to bathroom and could not stay awake for longer than 15 minutes during that time. Had fever of 101 for the next 24 hours while taking Tylenol. Then had fever of 100 for another 24 hours. The lymph node pain continued for a whole week with some swelling of lymph nodes in left armpit.

Other Meds: took Tylenol for fever

Current Illness: none

ID: 1561111
Sex: F
Age: 60
State:

Vax Date: 08/14/2021
Onset Date: 08/14/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Shaking chills, arm pain headache, fever, body aches

Other Meds: Paxil, Wellbutrin, protonix, propranolol, Enbrel (7 days prior), biotin, lysine, vitamin d

Current Illness:

ID: 1561112
Sex: F
Age: 72
State: WA

Vax Date: 08/05/2021
Onset Date: 08/14/2021
Rec V Date: 08/15/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Admitted to the hospital 8/14/2021 with acute pericarditis

Other Meds: methotrexate, oxycodone, among others

Current Illness:

ID: 1561113
Sex: F
Age: 76
State:

Vax Date: 02/17/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Arm was red; Arm was bumpy; Arm was warm to the touch; Broke out in bumps all over her back that are itching and she has been scratching; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm was red), PERIPHERAL SWELLING (Arm was bumpy), SKIN WARM (Arm was warm to the touch), PRURITUS (Broke out in bumps all over her back that are itching and she has been scratching) and NAUSEA (Nauseous) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20a) for COVID-19 vaccination. Concurrent medical conditions included Food allergy and Seasonal allergy. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced ERYTHEMA (Arm was red), PERIPHERAL SWELLING (Arm was bumpy), SKIN WARM (Arm was warm to the touch), PRURITUS (Broke out in bumps all over her back that are itching and she has been scratching) and NAUSEA (Nauseous). At the time of the report, ERYTHEMA (Arm was red), PERIPHERAL SWELLING (Arm was bumpy), SKIN WARM (Arm was warm to the touch), PRURITUS (Broke out in bumps all over her back that are itching and she has been scratching) and NAUSEA (Nauseous) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. It is reported that the itchiness is not as bad, the bumps are still there, and the nausea continues to reoccur No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness: Food allergy; Seasonal allergy

ID: 1561114
Sex: F
Age:
State:

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Arm is painful after the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is painful after the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm is painful after the injection). At the time of the report, PAIN IN EXTREMITY (Arm is painful after the injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. Treatment details was not provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1561115
Sex: M
Age: 39
State: OK

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (bloody nose) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced EPISTAXIS (bloody nose). At the time of the report, EPISTAXIS (bloody nose) outcome was unknown. Concomitant product use was not provided. No treatment was reported.

Other Meds:

Current Illness:

ID: 1561116
Sex: F
Age: 63
State: PA

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: arm sore really bad; Headache (pressure headache in forehead); Pain in the shoulder; stiff neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore really bad), HEADACHE (Headache (pressure headache in forehead)), ARTHRALGIA (Pain in the shoulder) and MUSCULOSKELETAL STIFFNESS (stiff neck) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm sore really bad), HEADACHE (Headache (pressure headache in forehead)), ARTHRALGIA (Pain in the shoulder) and MUSCULOSKELETAL STIFFNESS (stiff neck). On 02-Mar-2021, MUSCULOSKELETAL STIFFNESS (stiff neck) had resolved. At the time of the report, PAIN IN EXTREMITY (arm sore really bad), HEADACHE (Headache (pressure headache in forehead)) and ARTHRALGIA (Pain in the shoulder) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported .

Other Meds:

Current Illness:

ID: 1561117
Sex: F
Age:
State:

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Not sure if the vaccine was administer into the muscle or into the joint; Difficulty of moving it or raising it; Shooting pain down the arm when receiving the vaccine/Arm very tender and sore; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Not sure if the vaccine was administer into the muscle or into the joint), VACCINATION SITE MOVEMENT IMPAIRMENT (Difficulty of moving it or raising it) and VACCINATION SITE PAIN (Shooting pain down the arm when receiving the vaccine/Arm very tender and sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Not sure if the vaccine was administer into the muscle or into the joint), VACCINATION SITE MOVEMENT IMPAIRMENT (Difficulty of moving it or raising it) and VACCINATION SITE PAIN (Shooting pain down the arm when receiving the vaccine/Arm very tender and sore). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 01-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Not sure if the vaccine was administer into the muscle or into the joint) and VACCINATION SITE PAIN (Shooting pain down the arm when receiving the vaccine/Arm very tender and sore) had resolved. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Difficulty of moving it or raising it) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information included paracetamol and advil. No concomitant medication was provided. This case was linked to MOD-2021-031708 (Patient Link).; Sender's Comments: This report refers to a case of inappropriate route of vaccination for mRNA-1273, lot# 024M20A, with associated AEs. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1561118
Sex: F
Age: 74
State: CA

Vax Date: 02/06/2021
Onset Date: 02/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: LABORED BREATHING; redness; swelling; wheezing; coughing; fast heart beat; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), SWELLING (swelling), WHEEZING (wheezing), COUGH (coughing) and HEART RATE INCREASED (fast heart beat) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Insulin dependent diabetic and Obesity. On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced ERYTHEMA (redness), SWELLING (swelling), WHEEZING (wheezing), COUGH (coughing) and HEART RATE INCREASED (fast heart beat). On an unknown date, the patient experienced DYSPNOEA (LABORED BREATHING). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Wheezing and Labored breathing, at a dose of 1 dosage form. At the time of the report, ERYTHEMA (redness), SWELLING (swelling), COUGH (coughing) and HEART RATE INCREASED (fast heart beat) outcome was unknown and WHEEZING (wheezing) and DYSPNOEA (LABORED BREATHING) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient stated that she took pocket mouth mas and an emergency use bag with the help of her husband for breathing difficulty patient stated that due to fear she did not went hospital. Patient had obesity with body mass index30 to 33 No Concomitant medication reported by the reporter Patient experienced COVID-19 March to April This case was linked to MOD-2021-234141 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received on 30-APR-2021:Contains significant information: second dose date, relevant history -obesity, insulin dependent diabetes, treatment medication-Benadryl, event - labored breathing

Other Meds:

Current Illness: Insulin dependent diabetic; Obesity

ID: 1561119
Sex: F
Age:
State: NH

Vax Date: 02/20/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Itchy on injection site; Red on injection site; Hard to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy on injection site), VACCINATION SITE ERYTHEMA (Red on injection site) and VACCINATION SITE INDURATION (Hard to touch) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 27-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy on injection site), VACCINATION SITE ERYTHEMA (Red on injection site) and VACCINATION SITE INDURATION (Hard to touch). At the time of the report, VACCINATION SITE PRURITUS (Itchy on injection site), VACCINATION SITE ERYTHEMA (Red on injection site) and VACCINATION SITE INDURATION (Hard to touch) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication reported. Treatment for the event include hydrocortisone 1%.

Other Meds:

Current Illness:

ID: 1561120
Sex: F
Age: 35
State: NY

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: This spontaneous pregnancy case was reported by a consumer and describes the occurrence of BREAST FEEDING (breast feeding), PAIN (pain) and HEADACHE (headache) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced BREAST FEEDING (breast feeding), PAIN (pain) and HEADACHE (headache). At the time of the report, BREAST FEEDING (breast feeding), PAIN (pain) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant and treatment medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Non-significant Follow up Appended On 16-Jul-2021 and it mentioned - Reporter Email address updated.

Other Meds:

Current Illness:

ID: 1561121
Sex: F
Age:
State:

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Vaccine administered below deltoid; A spontaneous report was received from a Consumer concerning herself, a female patient of unspecified age, who received Moderna's COVID-19 vaccine (mRNA-1273) and who was administered vaccine below deltoid. No patient's medical history was reported. No relevant concomitant medications were provided. On 08 Mar 2021, prior to the onset of the events, the patient received their first of the two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route in left arm for prophylaxis of COVID-19 infection. On 08 Mar 2021, the patient was administered vaccine below deltoid.No Laboratory investigations were provided. No Treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable. The event administered vaccine belowdeltoid was considered resolved on 08 Mar 2021.; Reporter's Comments: This report refers to a case of Vaccine administered at inappropriate site for mRNA-1273, lot # unknown with no associated AEs.

Other Meds:

Current Illness:

ID: 1561122
Sex: F
Age: 70
State: WY

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Fast heart beat; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast heart beat) and MYALGIA (Sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced HEART RATE INCREASED (Fast heart beat) and MYALGIA (Sore arm). On 19-Feb-2021, HEART RATE INCREASED (Fast heart beat) and MYALGIA (Sore arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable No concomitant medications reported by investigator No treatment medications provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Non-significant follow received. Husband's email address provided.

Other Meds:

Current Illness:

ID: 1561123
Sex: F
Age: 77
State: FL

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Vaccination site pain; red swatches; rapid heartbeat; Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain), ERYTHEMA (red swatches), HEART RATE INCREASED (rapid heartbeat) and CHEST PAIN (Chest pain) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain), ERYTHEMA (red swatches), HEART RATE INCREASED (rapid heartbeat) and CHEST PAIN (Chest pain). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain), ERYTHEMA (red swatches), HEART RATE INCREASED (rapid heartbeat) and CHEST PAIN (Chest pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information not provided. List of concomitant medication were not given.

Other Meds:

Current Illness:

ID: 1561124
Sex: F
Age:
State: NC

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History Information was reported. On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided No relevant concomitant medications were reported. No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 12-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History Information was reported. On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1561125
Sex: M
Age: 70
State:

Vax Date: 02/08/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Malaise; Achiness; Dizziness; Diarrhea; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), PAIN (Achiness), DIZZINESS (Dizziness), DIARRHOEA (Diarrhea) and CHILLS (Chills) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced MALAISE (Malaise), PAIN (Achiness), DIZZINESS (Dizziness), DIARRHOEA (Diarrhea), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, MALAISE (Malaise), PAIN (Achiness), DIZZINESS (Dizziness), DIARRHOEA (Diarrhea), CHILLS (Chills) and HEADACHE (Headache) had resolved. No relevant concomitant medications were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable

Other Meds:

Current Illness:

ID: 1561126
Sex: F
Age: 47
State: NY

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: hurting; discomfort; is concerned; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (hurting), DISCOMFORT (discomfort) and ANXIETY (is concerned) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN (hurting), DISCOMFORT (discomfort) and ANXIETY (is concerned). At the time of the report, PAIN (hurting), DISCOMFORT (discomfort) and ANXIETY (is concerned) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. List of concomitant medication were not given. Treatment information not provided.

Other Meds:

Current Illness:

ID: 1561127
Sex: F
Age: 88
State: FL

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Light headed/ Dizzy; Throwing up; Fever; Sick to her stomach, nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed/ Dizzy), VOMITING (Throwing up), PYREXIA (Fever) and NAUSEA (Sick to her stomach, nausea) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced DIZZINESS (Light headed/ Dizzy), VOMITING (Throwing up), PYREXIA (Fever) and NAUSEA (Sick to her stomach, nausea). The patient was treated with ALUMINIUM HYDROXIDE, MAGNESIUM CARBONATE (GAVISCON [ALUMINIUM HYDROXIDE;MAGNESIUM CARBONATE]) at a dose of 1 dosage form. At the time of the report, DIZZINESS (Light headed/ Dizzy), VOMITING (Throwing up), PYREXIA (Fever) and NAUSEA (Sick to her stomach, nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medication information provided.

Other Meds:

Current Illness:

ID: 1561128
Sex: F
Age:
State: RI

Vax Date: 01/16/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: sore arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1561129
Sex: F
Age: 65
State: TN

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: her whole face was very swollen with no pain and she had swollen glands on her face and her; something inside her mouth busted and she experience "the most horrible bitter taste"; bitter taste and a hard time breathing; her arm became swollen and she started to experience a bitter taste (like lemon) and chills 3 or 4; her arm became swollen and she started to experience a bitter taste (like lemon) and chills 3 or 4; her arm became swollen and she started to experience a bitter taste (like lemon) and chills 3 or 4; A spontaneous report was received from a consumer concerning a 65-year-old female patient who experienced bitter taste, a hard time breathing/Dyspnoea, her whole face was very swollen with no pain and she had swollen glands on her face and her/Lymphadenopathy, something inside her mouth burst and she experienced "the most horrible bitter taste"/Oral discomfort , her arm became swollen/vaccination site welling, she started to experience a bitter taste/dysgeusia, chills/chills. On 23-Feb-2021, prior to the onset of the symptoms, the patient received their the patient received first of two planned doses of mRNA-1273 (Batch number:031L20A) for prophylaxis of COVID-19 infection. The patient's past medical history included sinus infection. Concomitant product use was not unknown On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 23-Feb-2021, the patient experienced peripheral swelling (her arm became swollen dysgeusia (she started to experience a bitter taste (like lemon) and chills. On 27-Feb-2021, the patient experienced dyspnea (hard time breathing) (seriousness criterion medically significant). On 28-Feb-2021, the patient experienced lymphadenopathy (her whole face was very swollen with no pain and she had swollen glands on her face and her) and oral discomfort (something inside her mouth busted and she experience "the most horrible bitter taste"). At the time of the report, dyspnea outcome was unknown and lymphadenopathy (her whole face was very swollen with no pain and she had swollen glands on her face ), oral discomfort (something inside her mouth busted and she experience d "the most horrible bitter taste"), peripheral swelling (her arm became swollen) , dysgeusia (she started to experience a bitter taste (like lemon) and chills had not been resolved. Treatment for the event included Ibuprofen. The outcome of the events were not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1561130
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Verbal aggresive; Memory problems; This spontaneous case was reported by a non-health professional and describes the occurrence of AGGRESSION (Verbal aggresive) and MEMORY IMPAIRMENT (Memory problems) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGGRESSION (Verbal aggresive) and MEMORY IMPAIRMENT (Memory problems). At the time of the report, AGGRESSION (Verbal aggresive) and MEMORY IMPAIRMENT (Memory problems) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1561131
Sex: M
Age: 54
State: NJ

Vax Date: 01/30/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: aches; Painful to Touch; swollen lymph node above collar bone on left side; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (aches), ALLODYNIA (Painful to Touch), LYMPHADENOPATHY (swollen lymph node above collar bone on left side) and PYREXIA (Fever) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 026L20A) for COVID-19 vaccination. Concurrent medical conditions included Parkinson's disease. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced MYALGIA (aches), LYMPHADENOPATHY (swollen lymph node above collar bone on left side) and PYREXIA (Fever). 27-Feb-2021, the patient experienced ALLODYNIA (Painful to Touch). The patient was treated with IBUPROFEN ongoing from 28-Feb-2021 for Adverse event, at a dose of 1 dosage form. At the time of the report, MYALGIA (aches), ALLODYNIA (Painful to Touch), LYMPHADENOPATHY (swollen lymph node above collar bone on left side) and PYREXIA (Fever) had resolved. The patient stated they were taking 130 pills a week for different issues. Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: event outcome of Lymphadenopathy changed to recovered.

Other Meds:

Current Illness: Parkinson's disease

ID: 1561132
Sex: F
Age: 71
State: CT

Vax Date: 02/20/2021
Onset Date: 02/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: lost taste; achy; soar arm; feels lousy; Headache; felt lethargic; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), LETHARGY (felt lethargic), AGEUSIA (lost taste), PAIN (achy) and PAIN IN EXTREMITY (soar arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Rhinitis and Drug allergy (Allergic to anti-inflammatories.). On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced HEADACHE (Headache), LETHARGY (felt lethargic), PAIN (achy), PAIN IN EXTREMITY (soar arm) and FEELING ABNORMAL (feels lousy). On 26-Feb-2021, the patient experienced AGEUSIA (lost taste). On 24-Feb-2021, PAIN (achy), PAIN IN EXTREMITY (soar arm) and FEELING ABNORMAL (feels lousy) had resolved. At the time of the report, HEADACHE (Headache) and LETHARGY (felt lethargic) had not resolved and AGEUSIA (lost taste) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported Treatment medications was not provided

Other Meds:

Current Illness: Drug allergy (Allergic to anti-inflammatories.); Rhinitis

ID: 1561133
Sex: M
Age: 53
State: NY

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Stuffy nose; More sinuses problems; Sinus pressure; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy nose), SINUS DISORDER (More sinuses problems) and PARANASAL SINUS DISCOMFORT (Sinus pressure) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Nose congestion. Concomitant products included METOPROLOL and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (Stuffy nose), SINUS DISORDER (More sinuses problems) and PARANASAL SINUS DISCOMFORT (Sinus pressure). The patient was treated with FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, NASAL CONGESTION (Stuffy nose), SINUS DISORDER (More sinuses problems) and PARANASAL SINUS DISCOMFORT (Sinus pressure) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant Medications include Cholesterol Medications, Flonase

Other Meds: METOPROLOL; BABY ASPIRIN

Current Illness: Nose congestion

ID: 1561134
Sex: M
Age: 74
State: TX

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: pain in both shoulders that is ongoing, the pain is worse in the right shoulder versus left; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in both shoulders that is ongoing, the pain is worse in the right shoulder versus left) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included LISINOPRIL and ASA for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced ARTHRALGIA (pain in both shoulders that is ongoing, the pain is worse in the right shoulder versus left). At the time of the report, ARTHRALGIA (pain in both shoulders that is ongoing, the pain is worse in the right shoulder versus left) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: LISINOPRIL; ASA

Current Illness:

ID: 1561135
Sex: F
Age: 69
State: NJ

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Last night, evening around 8pm, rash on torso, front and back, between breast and over whole; Sunday felt tired, took a nap for 3-4 hours; Second shot - soreness in location where vaccine administered on arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Last night, evening around 8pm, rash on torso, front and back, between breast and over whole), VACCINATION SITE PAIN (Second shot - soreness in location where vaccine administered on arm) and FATIGUE (Sunday felt tired, took a nap for 3-4 hours) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 029L20A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Allergy to Sulfa drugs). On 27-Feb-2021 at 1:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (Second shot - soreness in location where vaccine administered on arm). On an unknown date, the patient experienced RASH (Last night, evening around 8pm, rash on torso, front and back, between breast and over whole) and FATIGUE (Sunday felt tired, took a nap for 3-4 hours). At the time of the report, RASH (Last night, evening around 8pm, rash on torso, front and back, between breast and over whole) had not resolved and VACCINATION SITE PAIN (Second shot - soreness in location where vaccine administered on arm) and FATIGUE (Sunday felt tired, took a nap for 3-4 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness: Drug allergy (Allergy to Sulfa drugs)

ID: 1561136
Sex: F
Age:
State:

Vax Date:
Onset Date: 02/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment details included Not provided.

Other Meds:

Current Illness:

ID: 1561137
Sex: F
Age: 43
State: IL

Vax Date: 01/23/2021
Onset Date: 01/29/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: injection site was beet red; injection site was reallly hot; injection site was really hard; area around injection site itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site was beet red), VACCINATION SITE WARMTH (injection site was reallly hot), VACCINATION SITE INDURATION (injection site was really hard) and VACCINATION SITE PRURITUS (area around injection site itchy) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012m20a) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site was beet red), VACCINATION SITE WARMTH (injection site was reallly hot), VACCINATION SITE INDURATION (injection site was really hard) and VACCINATION SITE PRURITUS (area around injection site itchy). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (injection site was beet red), VACCINATION SITE WARMTH (injection site was reallly hot), VACCINATION SITE INDURATION (injection site was really hard) and VACCINATION SITE PRURITUS (area around injection site itchy) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1561138
Sex: F
Age: 55
State: NJ

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Itchiness; Redness; Swelling; Pain at injection site; Body Aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness), ERYTHEMA (Redness), SWELLING (Swelling), INJECTION SITE PAIN (Pain at injection site) and MYALGIA (Body Aches) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchiness), ERYTHEMA (Redness), SWELLING (Swelling), INJECTION SITE PAIN (Pain at injection site), MYALGIA (Body Aches) and CHILLS (chills). At the time of the report, PRURITUS (Itchiness), ERYTHEMA (Redness), SWELLING (Swelling), INJECTION SITE PAIN (Pain at injection site), MYALGIA (Body Aches) and CHILLS (chills) outcome was unknown. Benadryl used for treatment.

Other Meds:

Current Illness:

ID: 1561139
Sex: M
Age: 39
State: NC

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: pounding headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (pounding headache) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced HEADACHE (pounding headache). At the time of the report, HEADACHE (pounding headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1561140
Sex: F
Age: 76
State: FL

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: vomiting; fatigue; muscle aches; chills; increased hot flashes; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle aches), CHILLS (chills), HOT FLUSH (increased hot flashes) and VOMITING (vomiting) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included INFLIXIMAB (REMICADE), METHOTREXATE and TRAMADOL for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle aches), CHILLS (chills) and HOT FLUSH (increased hot flashes). On 01-Mar-2021, the patient experienced VOMITING (vomiting). At the time of the report, FATIGUE (fatigue), MYALGIA (muscle aches), CHILLS (chills), HOT FLUSH (increased hot flashes) and VOMITING (vomiting) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: REMICADE; METHOTREXATE; TRAMADOL

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm